FDAFDA recall D-0834-2026 · Sep 9, 2026
Teva Pharmaceuticals USA, Inc: traZODone Hydrochloride Tablets recall
Recall found
Product
traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 50111-560-01
Reason for recall
Presence of Foreign Tablets/Capsules
What to do
FDA enforcement reports don't include consumer instructions. Check the codes below against your packaging. If this is a medicine or device you use, talk to your pharmacist or doctor before you stop or change anything, and contact the company or FDA for what to do with the product.
Recall details
- FDA classification
- Class II: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
- Status
- Ongoing
- Codes, lots and dates
- Lot: 1394026, Exp. 02/2028.
- Quantity
- 175,392 bottles
- Distribution
- U.S. Nationwide
- Recalling firm
- Teva Pharmaceuticals USA, Inc, Parsippany, NJ
- Voluntary or mandated
- Voluntary: Firm initiated
- Recall started
- 2026-08-24
Source: openFDA enforcement record D-0834-2026 · search recall number D-0834-2026 in FDA's Enforcement Report.
Copied from the agency record without changes. Data as of Oct 22, 2026, 4:56 AM EDT. The agency notice is the final word.